Home » Newsletters » BioWorld Science

BioWorld Science

May 19, 2017

View Archived Issues

Animal model mimics social exclusion in depression

Aravax initiates clinical trials of PVX-108 to treat peanut allergy

BioAtla and Sinobioway expand CAB antibody collaboration

Pfizer initiates first-in-human study of PF-06667272

Amphivena initiates phase I trial of AMV-564 for AML

CHMP adopts negative opinion for masitinib in indolent systemic mastocytosis

FDA awards fast track designation to Sage Therapeutics' SAGE-217

Novel Zika VLP vaccine demonstrates enhanced efficacy in vivo

Albireo Pharma reveals phase III program for A-4250

ObsEva completes phase I drug-drug interaction study with OBE-022

HSV-1716 is safe and shows evidence of immune response and viral replication in phase I study

Roche divulges novel compounds for treating influenza

Esteve presents new sigma1-receptor ligands

SIWA Therapeutics provides update on SIWA-318 monoclonal antibody

Cinfa reports promising topline data on biosimilar pegfilgrastim

Noxxon signs clinical trial agreement for evaluation of NOX-A12 in combination with pembrolizumab

Pfizer's Xalkori approved for new indication in Japan

Thermo Fisher Scientific partners with Agios to develop ivosidenib companion diagnostic

Symic reports topline results from phase I/IIa study of SB-061 for osteoarthritis of the knee

Nuclear receptor ROR-gamma T inhibitor VPR-254 shows promise in colitis model

Amgen submits BLA for erenumab

FDA approves Keytruda for certain patients with locally advanced or metastatic urothelial carcinoma

mGlu5 receptor levels linked to post-traumatic stress disorder

Abide Therapeutics presents new preclinical and clinical data on ABX-1431

EMA committee hands down positive opinion on Veltassa for treatment of hyperkalemia

WHO prepares to deploy Ebola vaccine in latest outbreak

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...